Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Differential affinities of 5-(2-halogenovinyl)-2'-deoxyuridines for deoxythymidine kinases of various origins.

× No keyword cloud information.

30 in total

1. Novel ribofuranosylnucleoside lead compounds for potent and selective inhibitors of mitochondrial thymidine kinase-2.

Authors: J Balzarini; C Zhu; E De Clercq ; M J Pérez-Pérez; C Chamorro; M J Camarasa; A Karlsson
Journal: Biochem J Date: 2000-10-01 Impact factor: 3.857

2. Problems associated with the use of (E)-5-(2-bromovinyl)-2'-deoxyuridine for typing herpes simplex virus.

Authors: E M Swierkosz; M Q Arens; K A Rivetna
Journal: J Clin Microbiol Date: 1985-03 Impact factor: 5.948

3. Comparative efficacy and selectivity of some nucleoside analogs against Epstein-Barr virus.

Authors: J C Lin; M C Smith; J S Pagano
Journal: Antimicrob Agents Chemother Date: 1985-06 Impact factor: 5.191

4. Acyclic guanosine analogs as substrates for varicella-zoster virus thymidine kinase.

Authors: A R Karlström; C F Källander; G Abele; A Larsson
Journal: Antimicrob Agents Chemother Date: 1986-01 Impact factor: 5.191

5. Specific neuro-radiological diagnosis of herpes encephalitis in an animal model.

Authors: G M Cleator; P E Klapper; A G Lewis; H L Sharma; M Longson
Journal: Arch Virol Date: 1988 Impact factor: 2.574

6. Bromovinyldeoxyuridine and interferon treatment in ulcerative herpetic keratitis: a double masked study.

Authors: O P van Bijsterveld; P J Meurs; E de Clercq; P C Maudgal
Journal: Br J Ophthalmol Date: 1989-08 Impact factor: 4.638

7. Regeneration of the antiviral drug (E)-5-(2-bromovinyl)-2'-deoxyuridine in vivo.

Authors: C Desgranges; G Razaka; F Drouillet; H Bricaud; P Herdewijn; E De Clercq
Journal: Nucleic Acids Res Date: 1984-02-24 Impact factor: 16.971

8. Effect of (E)-5-(2-bromovinyl)-2'-deoxyuridine on synthesis of herpes simplex virus type 1-specific polypeptides.

Authors: S A Siegel; M J Otto; E De Clercq; W H Prusoff
Journal: Antimicrob Agents Chemother Date: 1984-05 Impact factor: 5.191

9. Treatment of experimental herpes simplex virus encephalitis with (E)-5-(2-bromovinyl)-2'-deoxyuridine in mice.

Authors: E de Clercq; Z X Zhang; I S Sim
Journal: Antimicrob Agents Chemother Date: 1982-09 Impact factor: 5.191

10. Mutant varicella-zoster virus thymidine kinase: correlation of clinical resistance and enzyme impairment.

Authors: G B Roberts; J A Fyfe; R K Gaillard; S A Short
Journal: J Virol Date: 1991-12 Impact factor: 5.103